Novogen Limited (Nasdaq: NVGN) 80.2% HIGHER; Novogen's subsidiary MEI Pharma (Nasdaq: MEIP), an oncology company focused on the clinical development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE